Carlos Zarate

1 presentation

• CLINICAL DEVELOPMENT OF (2R,6R)-HYDROXYNORKETAMINE: ONGOING TRIALS IN TRD AND OCD AND PHASE 1 SAFETY, TOLERABILITY, AND PK/PD RESULTS IN HEALTHY VOLUNTEERS

  2026 ASCP Annual Meeting